Vaccines against schistosomiasis: where do we stand?
- 1 January 1992
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 86 (1) , 1-2
- https://doi.org/10.1016/0035-9203(92)90411-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Morbidity, due to schistosomiasis mansoni, and its control in Subsaharan AfricaParasitology Today, 1991
- Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidityParasitology, 1991
- Differences in the rate of hepatosplenomegaly due to Schistosoma mansoni infection between two areas in Machakos District, KenyaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1991
- The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase.The Journal of Experimental Medicine, 1989
- Longitudinal studies on human schistosomiasisPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1988
- Immunity to Schistosomes: Progress Toward VaccineScience, 1987
- Molecular cloning of a protective antigen of schistosomesNature, 1987
- Eosinophilia and resistance to Schistosoma haematobium in manParasite Immunology, 1985
- Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responsesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1985
- Immunization of mice with gamma-irradiated intramuscularly injected schistosomula of Schistosoma mansoniParasitology, 1979